Revolution Medicines Inc

NASDAQ:RVMD 4:00:00 PM EDT

50.48

+0.98 (+1.98%)

: $50.23 -0.25 (-0.50%)

Market Cap (Intraday)	8.60B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.81 Million
Adjusted EPS	-$0.89

See more estimates

10-Day MA	$48.47
50-Day MA	$44.26
200-Day MA	$37.45

See more pivots

Revolution Medicines Inc Stock, NASDAQ:RVMD

700 Saginaw Drive, Redwood City, California 94063

United States of America

Phone: +1.650.481.6801

Number of Employees: 378

http://www.revmed.com

Description

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.